Literature DB >> 23382191

Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia.

Giuseppe Matarese1, Claudia La Rocca, Hyun-Seuk Moon, Joo Young Huh, Mary T Brinkoetter, Sharon Chou, Francesco Perna, Dario Greco, Holly P Kilim, Chuanyun Gao, Kalliope Arampatzi, Zhaoxi Wang, Christos S Mantzoros.   

Abstract

Leptin is an adipocyte-derived hormone that controls food intake and reproductive and immune functions in rodents. In uncontrolled human studies, low leptin levels are associated with impaired immune responses and reduced T-cell counts; however, the effects of leptin replacement on the adaptive immune system have not yet been reported in the context of randomized, controlled studies and/or in conditions of chronic acquired leptin deficiency. To address these questions, we performed a randomized, double-blinded, placebo-controlled trial of recombinant methionyl-human leptin (metreleptin) administration in replacement doses in women experiencing the female triad (hypothalamic amenorrhea) with acquired chronic hypoleptinemia induced by negative energy balance. Metreleptin restored both CD4(+) T-cell counts and their in vitro proliferative responses in these women. These changes were accompanied by a transcriptional signature in which genes relevant to cell survival and hormonal response were up-regulated, and apoptosis genes were down-regulated in circulating immune cells. We also observed that signaling pathways involved in cell growth/survival/proliferation, such as the STAT3, AMPK, mTOR, ERK1/2, and Akt pathways, were activated directly by acute in vivo metreleptin administration in peripheral blood mononuclear cells and CD4(+) T-cells both from subjects with chronic hypoleptinemia and from normoleptinemic, lean female subjects. Our data show that metreleptin administration, in doses that normalize circulating leptin levels, induces transcriptional changes, activates intracellular signaling pathways, and restores CD4(+) T-cell counts. Thus, metreleptin may prove to be a safe and effective therapy for selective CD4(+) T-cell immune reconstitution in hypoleptinemic states such as tuberculosis and HIV infection in which CD4(+) T cells are reduced.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23382191      PMCID: PMC3587204          DOI: 10.1073/pnas.1214554110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells.

Authors:  Hanno Hock; Stuart H Orkin
Journal:  Curr Opin Hematol       Date:  2006-01       Impact factor: 3.284

2.  Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in autosomal dominant vitiligo.

Authors:  Asem Alkhateeb; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2005-08       Impact factor: 8.551

Review 3.  Leptin regulation of the immune response and the immunodeficiency of malnutrition.

Authors:  R Faggioni; K R Feingold; C Grunfeld
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

4.  Leptin inhibits stress-induced apoptosis of T lymphocytes.

Authors:  Y Fujita; M Murakami; Y Ogawa; H Masuzaki; M Tanaka; S Ozaki; K Nakao; T Mimori
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  T cell factor-1 and β-catenin control the development of memory-like CD8 thymocytes.

Authors:  Archna Sharma; Qinghua Chen; Trang Nguyen; Qing Yu; Jyoti Misra Sen
Journal:  J Immunol       Date:  2012-04-15       Impact factor: 5.422

6.  Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation.

Authors:  Reinout van Crevel; Elvina Karyadi; Mihai G Netea; Hans Verhoef; Ronald H H Nelwan; Clive E West; Jos W M van der Meer
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

Review 7.  Leptin in immunology.

Authors:  Giuseppe Matarese; Stergios Moschos; Christos S Mantzoros
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

Review 8.  At the crossroad of T cells, adipose tissue, and diabetes.

Authors:  Giuseppe Matarese; Claudio Procaccini; Veronica De Rosa
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

9.  Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy.

Authors:  G Matarese; G Castelli-Gattinara; C Cancrini; S Bernardi; M L Romiti; C Savarese; A Di Giacomo; P Rossi; L Racioppi
Journal:  Clin Endocrinol (Oxf)       Date:  2002-11       Impact factor: 3.478

10.  Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.

Authors:  G M Lord; G Matarese; J K Howard; R J Baker; S R Bloom; R I Lechler
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

View more
  16 in total

1.  Dietary Indoles Suppress Delayed-Type Hypersensitivity by Inducing a Switch from Proinflammatory Th17 Cells to Anti-Inflammatory Regulatory T Cells through Regulation of MicroRNA.

Authors:  Narendra P Singh; Udai P Singh; Michael Rouse; Jiajia Zhang; Saurabh Chatterjee; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-12-28       Impact factor: 5.422

Review 2.  Leptin applications in 2015: what have we learned about leptin and obesity?

Authors:  Olivia M Farr; Anna Gavrieli; Christos S Mantzoros
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-10       Impact factor: 3.243

Review 3.  Leptin Involvement in Primary Brain and Pituitary Tumors: Therapeutic Potential, Prognostic Value, and Proposed Diagnostic Application.

Authors:  Christos Bikis; Theodora Tzanavari; Krystallenia I Alexandraki; Stamatios Theocharis
Journal:  Horm Cancer       Date:  2018-02-20       Impact factor: 3.869

Review 4.  Metreleptin: first global approval.

Authors:  Ken Chou; Caroline M Perry
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 5.  Leptin in the interplay of inflammation, metabolism and immune system disorders.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Jesús Pino; Miguel Angel Gonzalez-Gay; Juan J Gómez-Reino; Antonio Mera; Francisca Lago; Rodolfo Gómez; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

Review 6.  The role of leptin in regulating bone metabolism.

Authors:  Jagriti Upadhyay; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

7.  Identification and saturable nature of signaling pathways induced by metreleptin in humans: comparative evaluation of in vivo, ex vivo, and in vitro administration.

Authors:  Hyun-Seuk Moon; Joo Young Huh; Fadime Dincer; Benjamin E Schneider; Per-Olof Hasselgren; Christos S Mantzoros
Journal:  Diabetes       Date:  2014-09-23       Impact factor: 9.461

8.  Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment.

Authors:  John R Koethe; Cathy A Jenkins; Bryan Lau; Bryan E Shepherd; William Wester; Peter F Rebeiro; Michael J Silverberg; Jennifer E Thorne; John Gill; Angel M Mayor; Amanda Willig; Ronald Bosch; Michael A Horberg; Amy C Justice; Timothy R Sterling; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

Review 9.  Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism.

Authors:  Hyeong-Kyu Park; Rexford S Ahima
Journal:  Metabolism       Date:  2014-08-15       Impact factor: 8.694

Review 10.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.